The Successful Use of Telaprevir to Treat Hepatitis C Recurrence After Liver Transplantation in an HIV Co-Infected Patient

被引：2

作者：

Alkhouri, Naim ^{[1
]}

Singh, Gurshawn ^{[1
]}

Carey, William D. ^{[1
]}

Fung, John J. ^{[2
]}

Zein, Nizar N. ^{[1
]}

Eghtesad, Bijan ^{[2
]}

Taege, Alan ^{[3
]}

机构：

[1] Cleveland Clin Fdn, Inst Digest Dis, Dept Gastroenterol & Hepatol, Cleveland, OH 44195 USA

[2] Cleveland Clin Fdn, Inst Digest Dis, Dept Hepatopancreatobiliary & Transplant Surg, Cleveland, OH 44195 USA

[3] Cleveland Clin Fdn, Dept Infect Dis, Cleveland, OH 44195 USA

来源：

TRANSPLANTATION | 2014年 / 97卷 / 02期

关键词：

THERAPY; HCV;

D O I：

10.1097/01.tp.0000438633.06344.3a

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：E14 / E15

页数：2

共 8 条

[1] Protease inhibitors: Silver bullets for chronic hepatitis C infection? [J].

Alkhouri, Naim ;

Zein, Nizar N. .

CLEVELAND CLINIC JOURNAL OF MEDICINE, 2012, 79 (03) :213-222

[2] Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C [J].

de Vera, M. E. ;

Dvorchik, I. ;

Tom, K. ;

Eghtesad, B. ;

Thai, N. ;

Shakil, O. ;

Marcos, A. ;

Demetris, A. ;

Jain, A. ;

Fung, J. J. ;

Ragni, M. V. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (12) :2983-2993

[3] Liver transplantation in patients with HIV infection [J].

Fung, J ;

Eghtesad, B ;

Patel-Tom, K ;

DeVera, M ;

Chapman, H ;

Ragni, M .

LIVER TRANSPLANTATION, 2004, 10 (10) :S39-S53

[4] Outcome of HCV/HIV-Coinfected Liver Transplant Recipients: A Prospective and Multicenter Cohort Study [J].

Miro, J. M. ;

Montejo, M. ;

Castells, L. ;

Rafecas, A. ;

Moreno, S. ;

Agueero, F. ;

Abradelo, M. ;

Miralles, P. ;

Torre-Cisneros, J. ;

Pedreira, J. D. ;

Cordero, E. ;

de la Rosa, G. ;

Moyano, B. ;

Moreno, A. ;

Perez, I. ;

Rimola, A. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (07) :1866-1876

[5]

Norris Suzanne, 2008, Expert Rev Gastroenterol Hepatol, V2, P39, DOI 10.1586/17474124.2.1.39

[6] HCV therapy in HIV-infected patients [J].

Sulkowski, Mark S. .

LIVER INTERNATIONAL, 2013, 33 :63-67

[7] Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data [J].

Werner, Christoph R. ;

Egetemeyr, Daniel P. ;

Lauer, Ulrich M. ;

Nadalin, Silvio ;

Koenigsrainer, Alfred ;

Malek, Nisar P. ;

Berg, Christoph P. .

LIVER TRANSPLANTATION, 2012, 18 (12) :1464-1470

[8] A review of drug interactions with boceprevir and telaprevir: implications for HIV and transplant patients [J].

Wilby, Kyle J. ;

Greanya, Erica D. ;

Ford, Jo-Ann E. ;

Yoshida, Eric M. ;

Partovi, Nilufar .

ANNALS OF HEPATOLOGY, 2012, 11 (02) :179-185

← 1 →